Related Experiment Video
Updated: May 21, 2026
10:23
Synthesis of Cationized Magnetoferritin for Ultra-fast Magnetization of Cells
Published on: December 13, 2016
Magnetoferritin nanoparticles for targeting and visualizing tumour tissues
Kelong Fan1, Changqian Cao, Yongxin Pan
1Key Laboratory of Protein and Peptide Pharmaceutical, National Laboratory of Biomacromolecules, CAS-University of Tokyo Joint Laboratory of Structural Virology and Immunology, Institute of Biophysics, Chinese Academy of Sciences, 15 Datun Road, Beijing, China.
Nature Nanotechnology
|June 19, 2012
Summary
Magnetoferritin nanoparticles (M-HFn) visualize tumors without targeting agents. This novel approach offers high accuracy in distinguishing cancerous from normal cells, improving cancer diagnostics.
Area of Science:
- Biotechnology
- Nanomedicine
- Oncology
Background:
- Engineered nanoparticles are utilized for disease diagnostics and therapeutics.
- Current nanoparticle functionalization involves complex, costly methods leading to non-specific binding and reduced sensitivity.
Purpose of the Study:
- To develop a novel nanoparticle for tumor visualization without targeting ligands or contrast agents.
- To leverage the inherent properties of magnetoferritin nanoparticles (M-HFn) for cancer detection.
Main Methods:
- Iron oxide nanoparticles were encapsulated within a recombinant human heavy-chain ferritin (HFn) protein shell.
- The M-HFn nanoparticles target tumor cells overexpressing transferrin receptor 1 (TfR1).
- A colorimetric reaction, catalyzed by the iron oxide core, visualizes tumor tissues.
Main Results:
- M-HFn nanoparticles successfully targeted and visualized tumor tissues.
- The method demonstrated high diagnostic accuracy across 474 clinical specimens from nine cancer types.
- Achieved 98% sensitivity and 95% specificity in distinguishing cancerous from normal cells.
Conclusions:
- Magnetoferritin nanoparticles offer a ligand-free and contrast agent-free method for tumor visualization.
- This technique shows significant potential for improving cancer diagnostics with high sensitivity and specificity.
